Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This transcript is a long non-coding RNA (lncRNA) that is produced from the antisense strand of the *AVL9* locus (chromosome 7), designated ENSG00000293957. Antisense lncRNAs can modulate the expression of their sense protein-coding counterparts by affecting chromatin architecture, RNA stability, or transcript processing[2][4]. In humans and yeast, widespread antisense transcription can alter chromatin marks and gene expression dynamics near the promoter of the sense gene. For this transcript, such activity may theoretically influence the production, processing, and stability of *AVL9* mRNA and thereby indirectly affect cell migration or related biological processes governed by *AVL9*[3][4]. However, the clinical and functional significance of ENSG00000293957 remains uncharacterized, and it is not a therapeutic target nor recognized in structured drug-disease pathways.\nThere is no evidence of interaction with approved drugs, disease-modifying roles, or use as a biomarker. The entry likely represents a non-coding genomic feature without direct translational application.
Modulation of *AVL9* sense mRNA transcription via chromatin environment changes\nHistone acetylation modification affecting expression and transcript stability[2][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to AVL9 (ENSG00000293957).